HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Parasitic lung infections.

AbstractPURPOSE OF REVIEW:
Global climate change and population explosion leading to changes in natural ecosystem and travel across the continents have resulted in an increase in the transmission of parasites to human beings. This review focuses on recent advancements in parasitic lung infections.
RECENT FINDINGS:
Invasive parasitic diseases including lung infections are increasingly being reported in patients with immunodeficiency syndromes. A recombinant kinesin-related antigen of Leishmania donovani has been validated with ELISA using urine samples for the diagnosis of visceral leishmaniasis. Pyruvate kinase deficiency has been shown to provide protection against Plasmodium falciparum infection. Intravenous artesunate is an alternative drug for the treatment of severe malaria. The best way to protect from malaria is the use of long-lasting insecticide-treated bednets. Biennial treatment with praziquantel has been found to be cost-effective treatment for control of infection with Schistosoma haematobium. Pulmonary paragonimiasis can be diagnosed by fine needle aspiration biopsy of pulmonary nodules. Strongyloides stercoralis hyperinfection can mimic accelerated idiopathic pulmonary fibrosis. Migratory nodular shadows with halos are important chest computed tomographic findings in human toxocariasis.
SUMMARY:
Patients with immunodeficiency syndromes (HIV infection, organ transplantation and immunosuppressive drugs, including corticosteroids) should be evaluated for early detection of parasitic lung infections.
AuthorsVannan Kandi Vijayan
JournalCurrent opinion in pulmonary medicine (Curr Opin Pulm Med) Vol. 15 Issue 3 Pg. 274-82 (May 2009) ISSN: 1531-6971 [Electronic] United States
PMID19276810 (Publication Type: Journal Article, Review)
Chemical References
  • Antiparasitic Agents
  • Immunosuppressive Agents
Topics
  • Antiparasitic Agents (therapeutic use)
  • Greenhouse Effect
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents (adverse effects)
  • Lung Diseases, Parasitic (diagnosis, drug therapy, epidemiology)
  • Opportunistic Infections (diagnosis, epidemiology, parasitology)
  • Prevalence
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: